Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease
Anne M. Fagan(Washington University in St. Louis), Reisa A. Sperling(Harvard University), Stephen Salloway(Providence College), Peter R. Schofield(UNSW Sydney), Randall J. Bateman(Washington University in St. Louis), Daniel S. Marcus(Washington University in St. Louis), Martin N. Rossor(National Hospital for Neurology and Neurosurgery), Jack H. Ladenson(Jewish Hospital), Colin L. Masters(Mental Health Research Institute), Bernardino Ghetti(Indiana University School of Medicine), Chengjie Xiong(Washington University in St. Louis), John C. Morris(Washington University in St. Louis), Ralph N. Martins(Edith Cowan University), Virginia Buckles(Washington University in St. Louis), Richard Mayeux(Columbia University), Mateusz S. Jasielec(Washington University in St. Louis), John M. Ringman(University of California, Los Angeles), David M. Holtzman(Hope Center for Neurological Disorders), Alison Goate(Washington University in St. Louis), Tammie L.S. Benzinger(Washington University in St. Louis), Nigel J. Cairns(Washington University in St. Louis)
Cited by 439
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k